Dandekar Atul

Track

Insider profile

Dandekar Atul's trades of Maze Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-29 2026-07-29
PrS Proposed sale
74,814
315.62
US$405,728 		74,814 315.62 US$405,728
2026-07-01 2026-06-29
PlS Planned sale
28,654 -29.0%
221.63
US$4,318,891 		28,654 -29.0% 221.63 US$4,318,891
2026-06-02 2026-05-29
PlS Planned sale
18,136 +39.2%
409.27
US$2,662,541 		18,136 +39.2% 409.27 US$2,662,541
2026-05-01 2026-04-29
PlS Planned sale
7,500 -41.7%
25.37
US$190,299 		7,500 -41.7% 25.37 US$190,299
2026-04-01 2026-03-30
PlS Planned sale
790 -7.0%
30.02
US$23,714 		790 -7.0% 30.02 US$23,714
2026-04-01 2026-03-30
PlS Planned sale
6,710 -37.3%
29.26
US$196,305 		6,710 -37.3% 29.26 US$196,305
2026-03-30 2026-03-30
PrS Proposed sale
30,000
30.38
US$911,400 		30,000 30.38 US$911,400
2026-03-03 2026-02-27
PlS Planned sale
3,761 -26.4%
45.72
US$171,967 		3,761 -26.4% 45.72 US$171,967
2026-03-03 2026-02-27
PlS Planned sale
3,739 -20.8%
45.13
US$168,756 		3,739 -20.8% 45.13 US$168,756
2026-02-02 2026-01-29
PlS Planned sale
2,800 -21.0%
45.01
US$126,022 		2,800 -21.0% 45.01 US$126,022
2026-02-02 2026-01-29
PlS Planned sale
3,500 -20.8%
44.04
US$154,147 		3,500 -20.8% 44.04 US$154,147
2026-02-02 2026-01-29
PlS Planned sale
1,200 -6.7%
43.18
US$51,821 		1,200 -6.7% 43.18 US$51,821
2025-12-31 2025-12-30
PlS Planned sale
100 -0.9%
40.36
US$4,036 		100 -0.9% 40.36 US$4,036
2025-12-31 2025-12-29
PlS Planned sale
6,035 -36.5%
41.13
US$248,211 		6,035 -36.5% 41.13 US$248,211
2025-12-31 2025-12-29
PlS Planned sale
66,365 -80.1%
40.51
US$2,688,552 		66,365 -80.1% 40.51 US$2,688,552
2025-12-29 2025-12-29
PrS Proposed sale
87,500
42.10
US$3,683,750 		87,500 42.10 US$3,683,750